genetically humanized mouse model hepatitis c virus infection 
hepatitis c virus hcv remains major medical problem antiviral treatment partially effective vaccine exist development effective therapies hampered lack suitable small animal model although xenotransplantation immunodeficient mice human hepatocytes shown promise models subject important challenges building previous observation cd81 occludin comprise minimal human factors required render mouse cells permissive hcv entry vitro4 attempted murine humanization via genetic approach show expression two human genes sufficient allow hcv infection fully immunocompetent inbred mice establish precedent applying mouse genetics dissect viral entry validate role scavenger receptor type b class hcv uptake demonstrate hcv can blocked passive immunization well showing recombinant vaccinia virus vector induces humoral immunity confers partial protection heterologous challenge system recapitulates portion hcv life cycle immunocompetent rodent first time opening opportunities studying viral pathogenesis immunity comprising effective platform testing hcv entry inhibitors vivo 
